TABLE 2.
Variable | Survivors (n = 76) | Non‐survivors (n = 28) | Survivor v non‐survivor | AUC |
---|---|---|---|---|
Age | 55 (42–69) | 70 (48–79) | 0.02 | |
Female | 33 (43%) | 17 (61%) | NS | |
Ventilated | 12 (16%) | 8 (29%) | NS | |
CPAP | 20 (26%) | 14 (50%) | NS | |
Not ventilated | 44 (58%) | 6 (21%) | <0.0001 | |
Days in hospital | 9 (5–15) | 10 (6–116) | NS | |
PT (s) | 10.9 (10.5–11.7) | 11.6 (10.9–12.8) | 0.01 | 0.662 |
APTT (s) | 25.9 (23.4–29.2) | 32.5 (27.1–39.4) | <0.0001 | 0.771 |
Fibrinogen (g/L) | 5.77 (4.36–6.82) | 5.79 (3.9–6.85) | NS | 0.509 |
D‐dimer (mg/L) | 0.82 (0.49–2.00) | 3.06 (1.35–10.32) | <0.0001 | 0.767 |
Antithrombin (IU/mL) | 94.8 (81.5–104.9) | 96.6 (69.85–107.2) | NS | 0.515 |
WBC | 7.03 (4.85–9.25) | 11.00 (7.59–18.62) | 0.004 | 0.682 |
Neutrophils ×109/L | 5.67 (3.67–7.36) | 8.61 (6.11–13.20) | 0.003 | 0.687 |
Lymphocytes ×109/L | 0.90 (0.65–1.16) | 0.65 (0.50–0.85) | 0.02 | 0.651 |
Platelets ×109/L | 239 (187–307) | 224 (152–332) | NS | 0.599 |
TAT (ng/mL) | 5.8 (3.2–13.4) | 10.1 (7.4–22.1) | 0.006 | 0.677 |
sTM (TU/mL) | 10.0 (7.8–14.1) | 24.9 (17.9–42.5) | <0.0001 | 0.814 |
tPAI‐C (ng/mL) | 16.5 (12.2–25.0) | 26.9 (18.0–37.7) | 0.02 | 0.658 |
PIC (μg/mL) | 1.838 (1.201–2.850) | 2.278 (1.542–6.446) | NS | 0.620 |